pharmaceuticals 05 00553
TRANSCRIPT
-
7/31/2019 Pharmaceuticals 05 00553
1/38
mailto:[email protected]:[email protected]:[email protected] -
7/31/2019 Pharmaceuticals 05 00553
2/38
-
7/31/2019 Pharmaceuticals 05 00553
3/38
-
7/31/2019 Pharmaceuticals 05 00553
4/38
-
7/31/2019 Pharmaceuticals 05 00553
5/38
-
7/31/2019 Pharmaceuticals 05 00553
6/38
-
7/31/2019 Pharmaceuticals 05 00553
7/38
-
7/31/2019 Pharmaceuticals 05 00553
8/38
-
7/31/2019 Pharmaceuticals 05 00553
9/38
-
7/31/2019 Pharmaceuticals 05 00553
10/38
-
7/31/2019 Pharmaceuticals 05 00553
11/38
-
7/31/2019 Pharmaceuticals 05 00553
12/38
-
7/31/2019 Pharmaceuticals 05 00553
13/38
-
7/31/2019 Pharmaceuticals 05 00553
14/38
-
7/31/2019 Pharmaceuticals 05 00553
15/38
-
7/31/2019 Pharmaceuticals 05 00553
16/38
-
7/31/2019 Pharmaceuticals 05 00553
17/38
-
7/31/2019 Pharmaceuticals 05 00553
18/38
-
7/31/2019 Pharmaceuticals 05 00553
19/38
-
7/31/2019 Pharmaceuticals 05 00553
20/38
-
7/31/2019 Pharmaceuticals 05 00553
21/38
-
7/31/2019 Pharmaceuticals 05 00553
22/38
-
7/31/2019 Pharmaceuticals 05 00553
23/38
-
7/31/2019 Pharmaceuticals 05 00553
24/38
-
7/31/2019 Pharmaceuticals 05 00553
25/38
http://videocast.nih.gov/ram/rac061709.ramhttp://www.bloomberg.com/news/2012-03-16/neurologix-files-to-liquidate-under-chapter-7-bankruptcy-1-.html:http://www.bloomberg.com/news/2012-03-16/neurologix-files-to-liquidate-under-chapter-7-bankruptcy-1-.html: -
7/31/2019 Pharmaceuticals 05 00553
26/38
http://www.abedia.com/wiley/vectors.phphttp://www.oxfordbiomedica.co.uk/page.asp?pageid=59&newsid=302http://www.oxfordbiomedica.co.uk/page.asp?pageid=59&newsid=302 -
7/31/2019 Pharmaceuticals 05 00553
27/38
-
7/31/2019 Pharmaceuticals 05 00553
28/38
-
7/31/2019 Pharmaceuticals 05 00553
29/38
-
7/31/2019 Pharmaceuticals 05 00553
30/38
-
7/31/2019 Pharmaceuticals 05 00553
31/38
-
7/31/2019 Pharmaceuticals 05 00553
32/38
-
7/31/2019 Pharmaceuticals 05 00553
33/38
http://www.technologyreview.com/biomedicine/37708/?mod=chfeatured -
7/31/2019 Pharmaceuticals 05 00553
34/38
-
7/31/2019 Pharmaceuticals 05 00553
35/38
-
7/31/2019 Pharmaceuticals 05 00553
36/38
-
7/31/2019 Pharmaceuticals 05 00553
37/38
-
7/31/2019 Pharmaceuticals 05 00553
38/38
http://www.pdonlineresearch.org/responses/10602/345/regulated-gdnf-vectorshttp://www.pdonlineresearch.org/responses/10602/345/regulated-gdnf-vectors